IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Alex Lemonade Stand Foundation
Grant: N/A
National Cancer Institute
Grant: 1F31CA257757
National Cancer Institute
Grant: F31CA250401-01A1
National Cancer Institute
Grant: P30CA021765
National Cancer Institute
Grant: R01NS121249
National Cancer Institute
Grant: R01NS122859
NCI NIH HHS
Grant: F31 CA250401
NCI NIH HHS
Grant: F31 CA257757
National Institutes of Health
Grant: 3P30CA021765-41S2
Cancer Center Support Grant (CCSG)
National Institutes of Health
Grant: 5F31CA257757-02
Oncofetal TNC CAR T Cell Therapy for Pediatric Sarcoma
National Institutes of Health
Grant: 5R01NS122859-04
GENETICALLY ENGINEERED T CELLS FOR DIPG
National Institutes of Health
Grant: 5R01NS121249-02
Improving genetically engineered T cells for medulloblastomas
European Commission
Grant: 250401
European Union Contest for Young Scientists 2009
National Institutes of Health
Grant: 5F31CA250401-02
Development of Glypican-2 redirected T cells for the Treatment of Neuroblastoma
FWCI
3.68
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals